Abstract

An estimated 200 million people are infected worldwide with chronic hepatitis C (CHC) and insulin resistance (IR) is one of the pathological features of hepatitis C virus (HCV) infection. Retrospective analyses have estimated that approximately 21–24% of CHC patients are diabetic, with as many as 54% demonstrating IR

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call